Common Antioxidant Could Slow Symptoms of Aging in Human Skin

Common Antioxidant Could Slow Symptoms of Aging in Human Skin

Bookmark and Share


New work from the University of Maryland suggests that a common, inexpensive and safe chemical could slow the aging of human skin. UMD researchers found evidence that the chemical—an antioxidant called methylene blue—could slow or reverse several well-known signs of aging when tested in cultured human skin cells and simulated skin tissue. The study was published online in the journal Scientific Reports on May 30, 2017. 

Image of human skin models

“Our work suggests that methylene blue could be a powerful antioxidant for use in skin care products,” said Kan Cao, senior author on the study and an associate professor of cell biology and molecular genetics at UMD. “The effects we are seeing are not temporary. Methylene blue appears to make fundamental, long-term changes to skin cells.”

The researchers tested methylene blue for four weeks in skin cells from healthy middle-aged donors, as well as those diagnosed with progeria—a rare genetic disease that mimics the normal aging process at an accelerated rate. In addition to methylene blue, the researchers also tested three other known antioxidants: N-Acetyl-L-Cysteine (NAC), MitoQ and MitoTEMPO (mTEM).  

In these experiments, methylene blue outperformed the other three antioxidants, improving several age-related symptoms in cells from both healthy donors and progeria patients. The skin cells (fibroblasts, the cells that produce the structural protein collagen) experienced a decrease in damaging molecules known as reactive oxygen species, a reduced rate of cell death and an increase in the rate of cell division throughout the four-week treatment. 

Next, Cao and her colleagues tested methylene blue in fibroblasts from older donors (those over 80 years old) again for a period of four weeks. At the end of the treatment, the cells from older donors had experienced a range of improvements, including decreased expression of two genes commonly used as indicators of cellular aging: senescence-associated beta-galactosidase and p16. 

“I was encouraged and excited to see skin fibroblasts, derived from individuals more than 80 years old, grow much better in methylene blue-containing medium with reduced cellular senescence markers,” said Zheng-Mei Xiong, lead author of the study and an assistant research professor of cell biology and molecular genetics at UMD. “Methylene blue demonstrates a great potential to delay skin aging for all ages.”

The researchers then used simulated human skin (a system developed by Cao and Xiong) to perform several additional experiments. This simulated skin—a three-dimensional model made of living skin cells—includes all the major layers and structures of skin tissue, with the exception of hair follicles and sweat glands. The model skin could also be used in skin irritation tests required by the Food and Drug Administration for the approval of new cosmetic products, Cao said.

“This system allowed us to test a range of aging symptoms that we can’t replicate in cultured cells alone,” Cao said. “Most surprisingly, we saw that model skin treated with methylene blue retained more water and increased in thickness—both of which are features typical of younger skin.” 

The researchers also used the model skin to test the safety of cosmetic creams with methylene blue added. The results suggest that methylene blue causes little to no irritation, even at high concentrations. Encouraged by these results, Cao, Xiong and their colleagues hope to develop safe and effective ways for consumers to benefit from the properties of methylene blue. 

“We have already begun formulating cosmetics that contain methylene blue. Now we are looking to translate this into marketable products,” Cao said. “We are also very excited to develop the three-dimensional skin model system. Perhaps down the road we can customize the system with bioprinting, such that we might be able to use a patient’s own cells to provide a tailor-made testing platform specific to their needs.” 


Image: These cross-section images show three-dimensional human skin models made of living skin cells. Untreated model skin (left panel) shows a thinner dermis layer (black arrow) compared with model skin treated with the antioxidant methylene blue (right panel). A new study suggests that methylene blue could slow or reverse dermal thinning (a sign of aging) and a number of other symptoms of aging in human skin. Image credit: Zheng-Mei Xiong/University of Maryland

May 31, 2017


Prev   Next

Current Headlines

Start-up Born in UMD FPE Receives $1.2M Investment from Newly Established Maryland Momentum Fund

UMD Researchers Develop New Method for Electrogenic Devices to Control Cell Behavior

UMD Welcomes New VP for Research, Unveils New Vision for Strategic Impact

UMCP and UMB Celebrate 10 Years of Collaboration and MPowering the State

University of Maryland Announces Unprecedented Investment from the A. James & Alice B. Clark Foundation

UMD Awarded U.S. Department of Commerce Grant to Launch Immersive Media Innovation Ecosystem

UMD Research Administration Leader Receives Distinguished Service Award

UMD Professor's Startup Overcomes Challenges of Indoor Positioning Systems

News Resources

Return to Newsroom

Search News

Archived News

Events Resources

Events Calendar

Additional Resources

UM Newsdesk

Faculty Experts

Connect

social iconsFacebookTwitterLinkedInResearch News RSS Feed
Office of Technology Commercialization
2130 Mitchell Building
7999 Regents Dr.
University of Maryland
College Park, MD 20742

Phone: 301-405-3947  |  Fax: 301-314-9502
Email: umdtechtransfer@umd.edu

© Copyright 2013 University of Maryland

Did You Know

UMD's Neutral Buoyancy Research Facility, which simulates weightlessness, is one of only two such facilities in the U.S.